Spring til hovednavigation Spring til søgning Spring til hovedindhold

Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study

  • Mette Julsgaard*
  • , Signe Wildt
  • , Jens Kelsen
  • , NOVA Study Group
    • *Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Fingeraftryk

Udforsk hvilke forskningsemner 'Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study' indeholder.
Sorter

Keyphrases

Immunology and Microbiology